![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1279779
¼¼°èÀÇ °ø¸··»Áî ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)Global Scleral Lens Market Size study & Forecast, by Type by Application, by End User and Regional Analysis, 2022-2029 |
°ø¸··»Áî´Â ¿øÃß°¢¸· µî °¢¸·¿¡ ÀÌ»óÀÌ ÀÖ´Â »ç¶÷µéÀÇ ½Ã·Â±³Á¤¿¡ Æ¯ÈµÈ °¡½ºÅõ°ú¼º ·»ÁîÀÔ´Ï´Ù.
°¢¸· Ç¥¸éÀ» ¿ÏÀüÈ÷ µ¤±â ¶§¹®¿¡ ÀÏ¹Ý °¡½º Åõ°ú¼º ·»Á´Ù ¾ÈÁ¤¼ºÀÌ ³ôÀº °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌ ·»Áî´Â ¹æ»çÇü °¢¸· Àý°³¼ú, ½ºÆ¼ºì½º Á¸½¼ ÁõÈıº, ÀÌ½ÄÆí´ë¼÷ÁÖº´(GVHD), ¼î±×·» ÁõÈıº, ÈÇй°ÁúÀ̳ª È»ó ºÎ»óÀ» ÀÔÀº »ç¶÷µé¿¡°Ô ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¾È°ú ȯÀÚ Áõ°¡¿Í ¼¼°è¿¡¼ °ø¸··»ÁîÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÏ´Â µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ´ëü ±â¼úÀÇ ÀÌ¿ë °¡´É¼ºÀº ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
°ø¸··»Áî´Â ³ë¾È, ¿ø½Ã, ³½Ã, °¢¸·ÀÇ ¿äö, ¾È±¸ Ç¥¸é Áúȯ, ±Ù½Ã¿Í °°Àº ½Ã·Â ¹®Á¦¸¦ Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¿¹Ãø ±â°£ Áß ÀÌ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ø¸··»Áî ½ÃÀåÀÌ È°¼ºÈµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½Ì°¡Æ÷¸£, Çѱ¹, ÀϺ»À» Æ÷ÇÔÇÑ µ¿¾Æ½Ã¾Æ ±¹°¡µéÀº ±Ù½Ã ºóµµ°¡ °¡Àå ³ôÀ¸¸ç, National Center for Biotechnology InformationÀÇ 2019³â ±â»ç¿¡ µû¸£¸é 2050³â±îÁö ±Ù½Ã´Â ¼¼°è¿¡¼ 49¾ï 4,900¸¸ ¸í, °íµµ ±Ù½Ã´Â 9¾ï 2,500¸¸ ¸í¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±Ù½Ã À¯º´·ü Áõ°¡¿Í ±¼Àý ¹®Á¦¸¦ °³¼±Çϱâ À§ÇØ °ø¸··»Áî¿Í °°Àº ¾È°ú Á¦Ç°¿¡ ´ëÇÑ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ø¸··»Áî ½ÃÀåÀº ¾ÕÀ¸·Î ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ±â¼úÀÇ ¹ßÀü°ú ±Ù½Ã ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª °ø¸··»ÁîÀÇ ³ôÀº ºñ¿ëÀº 2022-2029³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
¼¼°èÀÇ °ø¸··»Áî ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¾È°ú Áúȯ ¹× ¾È°ú °ü·Ã ºÎ»ó Áõ°¡¿Í ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ¼öÀÍ Ãø¸é¿¡¼ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ë·É Àα¸ ¹× ´ë»ó Àα¸ Áõ°¡, Á¦Ç° °³¹ßÀ» À§ÇÑ Á¦ÈÞ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¿ª È®Àå, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹® ¹× ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ȯ°æ°ú °æÀï ±¸µµ¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.
Global Scleral Lens Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Scleral lenses are gas permeable lenses designed specifically for vision correction for those with Keratoconus and other corneal abnormalities. These lenses completely cover the corneal surface, giving them greater stability than typical gas permeable lenses. These lenses are widely used by people who have radial keratotomies, Stevens-Johnson Syndrome, Graft vs. Host Disease (GVHD), Sjogren's Syndrome, chemical or burn injuries, or who have had a radial keratotomy. The market is being driven by factors such as growing number of ophthalmic patients and increasing adoption of scleral lenses across the globe. However, availability of Alternative Techniques may hamper the market growth.
Scleral lenses are used to treat vision problems like presbyopia, hyperopia, astigmatism, uneven cornea, ocular surface disease, and myopia. Over the projection period, it is anticipated that the disease's rising prevalence would fuel the scleral lens market. According to the World Health Organization, East Asian nations including Singapore, South Korea, and Japan have the highest frequency of myopia. According to a 2019 article from the National Center for Biotechnology Information, by the year 2050, myopia and high myopia are anticipated to impact 4,949 million and 925 million individuals worldwide, respectively. The market for scleral lenses is anticipated to develop in the future due to the rising prevalence of myopia and rising spending on ophthalmic products like scleral lenses as a remedy for refractive problems. In addition, advancements in technology and rising prevelance of myopia disorder is creating lucrative growth to the market. However, the high cost of Scleral Lens stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Scleral Lens Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to rising prevelance of eye disorders, and eye related injury, and rising technological advancement. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.